Copper homeostasis and cuproptosis in cancer immunity and therapy
Immunological Reviews · 2024-01 · 321 (1) · 211-227
DOI: 10.1111/imr.13276 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 16.09.2023. Verfasst von Wei-Qing Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine-Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Copper, Neoplasms. Die Arbeit wurde bisher 174-mal zitiert (Crossref) und nennt 151 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Young and Middle-aged Academic and Technical Leaders Reserve Talents of Yunnan province, 535 Talent Project of First Affiliated Hospital of Kunming Medical University.
Abstract (Originalsprache)
Copper is an essential nutrient for maintaining enzyme activity and transcription factor function. Excess copper results in the aggregation of lipoylated dihydrolipoamide S‐acetyltransferase (DLAT), which correlates to the mitochondrial tricarboxylic acid (TCA) cycle, resulting in proteotoxic stress and eliciting a novel cell death modality: cuproptosis. Cuproptosis exerts an indispensable role in cancer progression, which is considered a promising strategy for cancer therapy. Cancer immunotherapy has gained extensive attention owing to breakthroughs in immune checkpoint blockade; furthermore, cuproptosis is strongly connected to the modulation of antitumor immunity. Thus, a thorough recognition concerning the mechanisms involved in the modulation of copper metabolism and cuproptosis may facilitate improvement in cancer management. This review outlines the cellular and molecular mechanisms and characteristics of cuproptosis and the links of the novel regulated cell death modality with human cancers. We also review the current knowledge on the complex effects of cuproptosis on antitumor immunity and immune response. Furthermore, potential agents that elicit cuproptosis pathways are summarized. Lastly, we discuss the influence of cuproptosis induction on the tumor microenvironment as well as the challenges of adding cuproptosis regulators to therapeutic strategies beyond traditional therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine-Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
ORCID-Profile: Wei-Qing Liu, Jun Yang
Förderung
- National Natural Science Foundation of China
- Young and Middle-aged Academic and Technical Leaders Reserve Talents of Yunnan province
- 535 Talent Project of First Affiliated Hospital of Kunming Medical University
- Yunnan Health Training Project of High Level Talents
- Yunnan Revitalization Talent Support Program
Zitieren
APA
Liu, W. Q., Lin, W. R., Yan, L., Xu, W. H., & Yang, J. (2024). Copper homeostasis and cuproptosis in cancer immunity and therapy. Immunological Reviews, 321(1), 211-227. https://doi.org/10.1111/imr.13276
Vancouver
Liu WQ, Lin WR, Yan L, Xu WH, Yang J. Copper homeostasis and cuproptosis in cancer immunity and therapy. Immunological Reviews. 2024;321(1):211-227. doi:10.1111/imr.13276
BibTeX
@article{Liu2024,
author = {Liu, Wei-Qing and Lin, Wan-Rong and Yan, Li and Xu, Wen-Hao and Yang, Jun},
title = {Copper homeostasis and cuproptosis in cancer immunity and therapy},
journal = {Immunological Reviews},
year = {2024},
volume = {321},
number = {1},
pages = {211--227},
doi = {10.1111/imr.13276}
}
EUVIMED